Related Experiment Video
Updated: Mar 24, 2026

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
CT-Based Annular Dimensions in Transcatheter Mitral Valve Replacement: A Multicenter Registry Study
Liliane Zillner1, Mirjam G Wild2, Michaela M Hell3
1Department of Cardiac and Thoracic Aortic Surgery, Medical University of Vienna, Austria.
Background:
Transcatheter mitral valve replacement (TMVR) is a preferred interventional option for high-risk patients with severe mitral regurgitation who are ineligible for transcatheter edge-to-edge repair. However, the role of annular dimensions in risk stratification has been marginally explored in this distinct anatomical setting with preserved native leaflets in patients with varying degree of myocardial damage.
Methods:
This subanalysis of the multicenter TENDER registry (NCT04898335) included 145 TMVR patients. Preprocedural 4D-computed tomography-derived annular dimensions were evaluated for associations with cardiac and all-cause mortality.
Results:
At 1 year, all-cause mortality was 24.8% (n = 36 of 145) and cardiac mortality was 5.5% (n = 8 of 145). Cardiac deaths were associated with significantly larger annular parameters, including systolic and diastolic anteroposterior diameter (32.8 ± 2.3 mm vs 29.9 ± 3.5 mm, P = .023; 33.2 ± 2.5 mm vs 30.3 ± 3.4 mm, P = .018), systolic and diastolic annular perimeter (126.1 ± 9.5 mm vs 115.8 ± 10.5 mm, P = .008; 125.6 ± 10.4 mm vs 115.8 ± 12.7 mm, P = .034), and annular area (1271.7 ± 193.2 mm2 vs 1076.2 ± 193.6 mm2, P = .006; 1262.7 ± 209.9 mm2 vs 1087.2 ± 194.7 mm2, P = .015). Annular area loss, calculated as the difference between native diastolic mitral annular area and the geometric effective orifice area of the implanted valve, was significantly greater in patients who died for cardiac reasons (999.72 ± 225.72 mm2) compared with survivors (826.68 ± 189.45 mm2; P = .022; odds ratio, 1.005, P = .030).
Conclusions:
Larger annular dimensions and greater annular area loss may predict 1-year cardiac death. Possible mechanisms include impaired left ventricle filling, artificial inflow-related outflow tract obstruction, and limited reverse remodeling. Comprehensive annular assessment may also enhance patient selection for future transseptal TMVR systems.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis III: Medical Management

